The long-term clinical impact of digital endpoints and biomarkers in data collection
Expert Review of Pharmacoeconomics & Outcomes Research · 2024
DOI: 10.1080/14737167.2024.2320233 ↗Kurz gefasst
Editorial in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2024. Verfasst von Ahmad Z Al Meslamani. Beteiligte Einrichtung: College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Biomarkers, Data Collection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
1. Traditional endpoints in clinical trials are predefined outcomes used to measure the efficacy and safety of interventions. They have been the cornerstone of regulatory approval for new treatment...
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
- AAU Health and Biomedical Research quality of care Center, Al Ain University, Abu Dhabi, United Arab Emirates.
Zitieren
APA
Al Meslamani, A. Z. (2024). The long-term clinical impact of digital endpoints and biomarkers in data collection. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2024.2320233
Vancouver
Al Meslamani AZ. The long-term clinical impact of digital endpoints and biomarkers in data collection. Expert Review of Pharmacoeconomics & Outcomes Research. 2024. doi:10.1080/14737167.2024.2320233
BibTeX
@article{AlMeslamani2024,
author = {Al Meslamani, Ahmad Z},
title = {The long-term clinical impact of digital endpoints and biomarkers in data collection},
journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
year = {2024},
doi = {10.1080/14737167.2024.2320233}
}
EUVIMED